Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Closes $1.1B BioSpin Acquisition

NEW YORK (GenomeWeb News) – Bruker BioSciences announced after the close of the market last night that it has completed its acquisition of Bruker BioSpin and has been renamed Bruker Corp.
Roughly 57.5 million shares of new, unregistered Bruker common stock worth around $624.9 million were issued for the stock component of the deal. Combined with the $388 million cash component of the deal, the total value of the acquisition is nearly $100 million more than when Bruker announced its intention to buy BioSpin in early December.
Following completion of the acquisition, Bruker will operate in two segments: the life science and analytical systems segment, and the international advanced superconductor segment.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.